Mallory D. Witt is a Professor of Clinical Medicine at the David Geffen School of Medicine at UCLA, and an investigator at the Lundquist Institute for Biomedical Innovation. Teaching and mentorship are her top priorities. She attends on the inpatient Immunocompromise Service at Harbor-UCLA, supervises fellows and other clinicians in the Positive Care Clinic at Harbor-UCLA, and regularly provides interactive lectures to IM residents, ID fellows, as well as to trainees in other departments.
Dr. Witt has served as the site Principal Investigator for a wide variety of federal and state funded studies of HIV and its complications. She is a Principal Investigator for the combined Multicenter AIDS Cohort Study/Women’s Interagency Cohort Study (MWCCS), a longstanding study of the natural history of HIV infection and its complications, viral hepatitis and other co-infections, and complications of HIV therapies, and also serves as a co-investigator in the AIDS Clinical Trials Group (ACTG).
Dr. Witt’s research interests include evaluation of cardiovascular complications of HIV and its therapies, as well as hepatic, neurologic, metabolic and renal complications of HIV disease.
Dr. Witt received her MD from the Stanford University School of Medicine, completed internship and residency at UCSF, followed by Infectious Disease fellowship training at Harbor-UCLA. She is a fellow of the American College of Physicians as well as the Infectious Disease Society of America, and is certified by the American Academy of HIV Medicine. She serves as Chair of the Bioethics Committee at Harbor-UCLA.